Echinococcus granulosus: immunodiagnosis and vaccination, a perspective

Area of Science:

• * Parasitology
• * Immunology
• * Veterinary Medicine

Background:

• * Cystic Echinococcosis (CE) is a significant zoonotic parasitic disease with global health and economic impacts.
• * Current diagnostic methods for CE have limitations in specificity and sensitivity.
• * Vaccination strategies are crucial for controlling the spread of CE in livestock populations.

Purpose of the Study:

• * To review recent progress in immunodiagnosis and vaccination for Cystic Echinococcosis.
• * To evaluate improvements in diagnostic specificity for human CE and sensitivity/specificity for ovine CE using purified Ag B subunit peptides.
• * To compare the efficacy of coproantigen test ELISA with the arecoline purgation test for diagnosing definitive hosts.

Main Methods:

• * Review of existing research on immunodiagnosis and vaccination in CE.
• * Analysis of studies utilizing purified subunit peptides of Antigen B (Ag B) for improved diagnostic accuracy.
• * Comparative assessment of diagnostic techniques, including ELISA-based coproantigen tests and traditional methods.

Main Results:

• * Purification of Ag B subunit peptides has led to enhanced specificity in human CE immunodiagnosis.
• * Improved sensitivity and specificity in ovine CE diagnosis have been achieved using purified Ag B peptides.
• * Enzyme-linked immunosorbent assay (ELISA) coproantigen tests demonstrate advantages over the arecoline purgation test for definitive host diagnosis.

Conclusions:

• * Advances in immunodiagnosis, particularly using purified Ag B peptides, offer more accurate CE detection in both humans and animals.
• * Coproantigen tests represent a valuable tool for diagnosing definitive hosts, aiding in disease surveillance.
• * Effective vaccination holds immense potential for the successful control of Hydatid disease through integrated management programs.